Hematologic toxicities in cancer patients treated with the multi-tyrosine kinase sorafenib: A meta-analysis of clinical trials & T* I+ e0 { q+ j$ N6 m, R9 L; t
http://apps.webofknowledge.com/full_record.do?product=UA&search_mode=GeneralSearch&qid=2&SID=3ElacPLA2LMG1368EmG&page=1&doc=3